Inappropriate ICD shocks are common adverse events; they are mainly due to supraventricular arrhythmias and secondly are related to noise, undersensing, oversensing, device malfunctions. We present a case of inappropriate device therapy due to myopotential oversensing in a patient with a subcutaneous ICD (s-ICD). A 58 years old male with an s-ICD during the device interrogation showed a previous episode of suspected sustained ventricular tachycardia at 210 bpm, which was effectively treated with ICD shock. The patient experienced the electrical shock while holding a big gas-cylinder in his arms. The EGM analysis revealed many irregular ventricular signals of low amplitude lasting for 24 s and interrupted by the shock. The device showed no m...
A 53-year-old female patient with hypertrophic obstructive cardiomyopathy (HOCM) was admitted for al...
BACKGROUND Subcutaneous implantable cardioverter-defibrillator (S-ICD) implantations are rapidly exp...
AbstractThe ventricular tachycardia (VT) monitoring zone in implantable cardioverter defibrillators ...
Inappropriate ICD shocks are common adverse events; they are mainly due to supraventricular arrhythm...
AbstractInappropriate ICD shocks are common adverse events; they are mainly due to supraventricular ...
BACKGROUND: The entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) eliminates the ...
AbstractHypertrophic cardiomyopathy’s (HCM) association with sudden cardiac death is well recognised...
Ventricular oversensing in patients with defibrillators is an infrequent but deleterious condition. ...
Background: The subcutaneous implantable cardioverter defibrillator (S-ICD) is an established treatm...
AIMS Subcutaneous implantable cardioverter defibrillators (S-ICDs) are well established. However,...
BACKGROUND: Inappropriate shocks (IASs) complicate implantable cardioverter-defibrillator (ICD) ther...
AbstractVentricular oversensing in patients with defibrillators is an infrequent but deleterious con...
A 64-year-old male with a high body mass index, and subcutaneous implantable cardioverter defibrilla...
Background: T wave over sensing (TWOS) is a known phenomenon with trans-venous and subcutaneous ICDs...
BACKGROUND Subcutaneous implantable cardioverter-defibrillator (S-ICD) implantations are rapidly exp...
A 53-year-old female patient with hypertrophic obstructive cardiomyopathy (HOCM) was admitted for al...
BACKGROUND Subcutaneous implantable cardioverter-defibrillator (S-ICD) implantations are rapidly exp...
AbstractThe ventricular tachycardia (VT) monitoring zone in implantable cardioverter defibrillators ...
Inappropriate ICD shocks are common adverse events; they are mainly due to supraventricular arrhythm...
AbstractInappropriate ICD shocks are common adverse events; they are mainly due to supraventricular ...
BACKGROUND: The entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) eliminates the ...
AbstractHypertrophic cardiomyopathy’s (HCM) association with sudden cardiac death is well recognised...
Ventricular oversensing in patients with defibrillators is an infrequent but deleterious condition. ...
Background: The subcutaneous implantable cardioverter defibrillator (S-ICD) is an established treatm...
AIMS Subcutaneous implantable cardioverter defibrillators (S-ICDs) are well established. However,...
BACKGROUND: Inappropriate shocks (IASs) complicate implantable cardioverter-defibrillator (ICD) ther...
AbstractVentricular oversensing in patients with defibrillators is an infrequent but deleterious con...
A 64-year-old male with a high body mass index, and subcutaneous implantable cardioverter defibrilla...
Background: T wave over sensing (TWOS) is a known phenomenon with trans-venous and subcutaneous ICDs...
BACKGROUND Subcutaneous implantable cardioverter-defibrillator (S-ICD) implantations are rapidly exp...
A 53-year-old female patient with hypertrophic obstructive cardiomyopathy (HOCM) was admitted for al...
BACKGROUND Subcutaneous implantable cardioverter-defibrillator (S-ICD) implantations are rapidly exp...
AbstractThe ventricular tachycardia (VT) monitoring zone in implantable cardioverter defibrillators ...